| Trial ID: | L2846 |
| Source ID: | NCT00974272
|
| Associated Drug: |
Exenatide
|
| Title: |
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Impaired Glucose Tolerance
|
| Interventions: |
DRUG: Exenatide|OTHER: Normal Saline
|
| Outcome Measures: |
Primary: Triglyceride concentration in serum, Before and up to 8-hours post-injection | Secondary: serum or plasma lipoproteins, apolipoproteins and inflammatory markers; endothelial function, Before and up to 8 hours post-injection
|
| Sponsor/Collaborators: |
Sponsor: Carl T. Hayden VA Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
39
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
2008-11
|
| Results First Posted: |
|
| Last Update Posted: |
2009-09-10
|
| Locations: |
Phoenix VA Medical Center, Phoenix, Arizona, 85012, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00974272
|
